NCT01365156View on ClinicalTrials.gov

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 24, 2020

Study Completion Date

January 24, 2020

Conditions
Cervical Squamous Cell CarcinomaAdenosquamous CarcinomaAdenocarcinomaLocally Advanced Malignant NeoplasmCervical Cancer
Interventions
PROCEDURE

Extraperitoneal laparoscopic lymphadenectomy (EPLND)

Laparoscopic surgical procedure to remove and examine lymph nodes in abdomen, 7-10 days before chemoradiation treatment

RADIATION

Chemoradiation

Radiation for 5 days in a row for 5 to 5½ weeks plus Cisplatin Chemotherapy cisplatin chemotherapy by vein over about 2 hours, 1 time every week for about 6 weeks.

Trial Locations (3)

77026

Lyndon B. Johnson General Hospital, Houston

77030

University of Texas MD Anderson Cancer Center, Houston

Unknown

Vall d'Hebron Hospital, Brussels

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01365156 - Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix | Biotech Hunter | Biotech Hunter